Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings Analysis
Rapport Therapeutics, Inc. Common Stock (RAPP) next reports earnings on 2026-08-06, consensus EPS -0.97128 USD. Last quarter (2026-05-07) it beat with EPS -0.42 USD vs -0.56 USD est (+25%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -15.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RAPP next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.97128 USD |
| Revenue estimate | 0.00B |
RAPP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.42 USD | -0.56 USD | +25% | Beat |
| 2026-03-10 | -0.72 USD | -0.65 USD | -10.8% | Miss |
| 2025-11-06 | -0.71 USD | -0.77 USD | +7.8% | Beat |
| 2025-08-07 | -0.75 USD | -0.87 USD | +13.8% | Beat |
| 2025-03-11 | -0.57 USD | -0.62 USD | +8.1% | Beat |
| 2024-11-07 | -0.5 USD | -0.57 USD | +12.3% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
RAPP valuation and analyst view
| Trailing P/E | -15.90 |
|---|---|
| Trailing EPS | -2.27106 USD |
| Price / book | 4.14 |
| Dividend yield | 0.00% |
| Market cap | 1.50B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 57.67 USD |
Related research pages
Frequently asked questions
When is Rapport Therapeutics, Inc. Common Stock (RAPP)'s next earnings date?
Rapport Therapeutics, Inc. Common Stock is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.97128 USD and revenue estimate of 0.00B.
Did RAPP beat earnings last quarter?
In its 2026-05-07 report, RAPP posted EPS of -0.42 USD versus a -0.56 USD estimate — a beat of 25%.
What is RAPP's earnings track record?
Over the last 6 reported quarters with consensus data, RAPP beat estimates 5 times (83%).
What is RAPP's current P/E ratio and EPS?
RAPP trades at a trailing P/E of -15.90 on trailing EPS of -2.271055899895289 USD.
What do analysts rate RAPP?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 57.67 USD.